Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
20 Nov 2024
COVID-19 Linked to Long-Term Connective Tissue Disorder Risks
The findings suggest that healthcare systems must prioritise post-COVID-19 care, with a focus on identifying and managing autoimmune and autoinflammatory disorders.
19 Nov 2024
Machine Learning Models Predict Success in Stopping Renal Replacement Therapy
Machine learning identifies key factors and predicts success in renal replacement therapy discontinuation for critically ill patients with acute kidney injury.
Novartis takes the top spot in 2024 Access to Medicine Index
Novartis has claimed the top spot in the 2024 Access to Medicine Index, displacing GSK after 16 consecutive years at the top.
19 Nov 2024
Rising Trends in Germline Genetic Testing for Prostate Cancer
Recent data shows a significant increase in germline genetic testing for prostate cancer, with a notable rise in urologist involvement.
19 Nov 2024
Which Treatment for Malignant Pleural Effusions Works Best?
No difference in mortality found between indwelling pleural catheters and chemical pleurodesis for treating malignant pleural effusions.
19 Nov 2024
New Study Evaluates VR/AR Headset Accuracy in Diagnosing Diverticulitis
VR/AR headsets could one day match desktops in diagnostic effectiveness, according to a recent study.
19 Nov 2024
Meta-Analysis Reveals Impact of Hypotension on TBI Mortality
Patients with traumatic brain injury (TBI) and hypotension face doubled mortality odds, highlighting the need for precise blood pressure management in clinical practice.
19 Nov 2024
Does Retreating Multiple Myeloma with Previously Refractory Drugs Work?
Patients with late line relapsed/refractory multiple myeloma (RRMM) could benefit from repeat treatment with drugs their disease has previously been refractory to.
19 Nov 2024
GLP-1 Agonists May Help Reduce Alcohol-Related Hospitalisations
Glucagon-like peptide-1 receptor (GLP-1) agonists, particularly semaglutide, could be effective in reducing alcohol-related hospitalisations.
Alfasigma’s Patrick Oliver on the company’s new chapter in the UK
Patrick Oliver, General Manager for the UK and Ireland at Alfasigma explores the company’s exciting entry into the UK market and the evolving healthcare landscape in the country.
←
1
2
3
…
34
35
36
37
38
39
40
…
980
981
982
→